U.S. Physical Therapy (NYSE:USPH) Earns Market Perform Rating from William Blair

U.S. Physical Therapy (NYSE:USPH)‘s stock had its “market perform” rating reaffirmed by research analysts at William Blair in a research note issued to investors on Thursday,RTT News reports. William Blair also issued estimates for U.S. Physical Therapy’s Q1 2025 earnings at $0.56 EPS, Q1 2025 earnings at $0.56 EPS, Q2 2025 earnings at $0.79 EPS, Q2 2025 earnings at $0.79 EPS, Q4 2025 earnings at $0.78 EPS, Q4 2025 earnings at $0.78 EPS, FY2025 earnings at $2.96 EPS and FY2025 earnings at $2.96 EPS.

A number of other research firms also recently issued reports on USPH. Barrington Research reaffirmed an “outperform” rating and issued a $108.00 target price on shares of U.S. Physical Therapy in a research report on Thursday, November 21st. JPMorgan Chase & Co. raised their price target on U.S. Physical Therapy from $117.00 to $120.00 and gave the company an “overweight” rating in a research note on Tuesday, December 3rd. Bank of America upgraded U.S. Physical Therapy from a “neutral” rating to a “buy” rating and upped their price objective for the stock from $100.00 to $115.00 in a research note on Monday, December 16th. Citizens Jmp raised shares of U.S. Physical Therapy to a “strong-buy” rating in a research note on Monday, December 16th. Finally, JMP Securities initiated coverage on shares of U.S. Physical Therapy in a report on Monday, December 16th. They set an “outperform” rating and a $113.00 target price on the stock. One analyst has rated the stock with a sell rating, one has issued a hold rating, four have issued a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, U.S. Physical Therapy presently has a consensus rating of “Moderate Buy” and a consensus price target of $111.50.

U.S. Physical Therapy Trading Down 1.6 %

NYSE:USPH opened at $81.08 on Thursday. The company has a quick ratio of 1.78, a current ratio of 1.78 and a debt-to-equity ratio of 0.27. U.S. Physical Therapy has a twelve month low of $76.18 and a twelve month high of $113.63. The company has a market cap of $1.22 billion, a P/E ratio of 86.26, a price-to-earnings-growth ratio of 3.54 and a beta of 1.48. The business has a 50 day moving average price of $88.41 and a two-hundred day moving average price of $87.67.

U.S. Physical Therapy (NYSE:USPH) last announced its earnings results on Wednesday, February 26th. The company reported $0.65 EPS for the quarter, missing the consensus estimate of $0.69 by ($0.04). U.S. Physical Therapy had a return on equity of 8.11% and a net margin of 3.54%. The business had revenue of $180.45 million for the quarter, compared to analyst estimates of $173.10 million. As a group, analysts expect that U.S. Physical Therapy will post 2.67 EPS for the current fiscal year.

Insider Buying and Selling

In other news, CFO Carey P. Hendrickson sold 516 shares of the firm’s stock in a transaction dated Monday, December 9th. The shares were sold at an average price of $96.25, for a total transaction of $49,665.00. Following the completion of the sale, the chief financial officer now owns 20,469 shares in the company, valued at approximately $1,970,141.25. This trade represents a 2.46 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. 1.70% of the stock is owned by insiders.

Hedge Funds Weigh In On U.S. Physical Therapy

Institutional investors and hedge funds have recently made changes to their positions in the company. CBIZ Investment Advisory Services LLC boosted its holdings in shares of U.S. Physical Therapy by 59.8% in the 4th quarter. CBIZ Investment Advisory Services LLC now owns 326 shares of the company’s stock valued at $29,000 after purchasing an additional 122 shares in the last quarter. Point72 Asia Singapore Pte. Ltd. acquired a new position in shares of U.S. Physical Therapy in the 4th quarter worth approximately $39,000. Venturi Wealth Management LLC boosted its stake in shares of U.S. Physical Therapy by 3,200.0% in the 4th quarter. Venturi Wealth Management LLC now owns 726 shares of the company’s stock valued at $64,000 after purchasing an additional 704 shares during the last quarter. KBC Group NV increased its position in shares of U.S. Physical Therapy by 68.6% during the third quarter. KBC Group NV now owns 774 shares of the company’s stock worth $66,000 after buying an additional 315 shares during the period. Finally, Lazard Asset Management LLC bought a new position in U.S. Physical Therapy during the fourth quarter worth $84,000.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.